bluebird bio
O. James Sterling serves as Chief Financial Officer at bluebird bio and has held several key roles in finance and leadership across various companies. Sterling is a Member of the Board of Directors and Chair of the Audit Committee at Star Mountain Lower Middle-Market Capital Corp. Previously, Sterling was Chief Financial Officer at Renalytix and held the position of Partner at Renwick Capital, LLC. Additionally, Sterling served as Managing Director in Investment Banking at Brock Capital Group LLC.
This person is not in any teams
This person is not in any offices
bluebird bio
40 followers
bluebird bio is developing innovative gene therapies for severe genetic diseases and cancer. Its vision is to make the hope of gene therapy a reality.